Key Financials Snapshot

TTM · Consolidated · ₹ in Cr
Market Cap
₹6649 Cr.
Stock P/E
39.3
P/B
3.2
Current Price
₹2052.2
Book Value
₹ 634.1
Face Value
2
52W High
₹2628
52W Low
₹ 905.2
Dividend Yield
0.54%

Balaji Amines Overview

Business

Balaji Amines Ltd. is a leading Indian manufacturer of aliphatic amines and their derivatives. The company's core business involves producing various methylamines, ethylamines, specialty chemicals, and pharma intermediates. These products serve diverse end-user industries, including pharmaceuticals, agrochemicals, rubber chemicals, water treatment chemicals, and solvents. Balaji Amines primarily makes money by manufacturing and selling these chemical compounds to industrial clients, often through long-term supply agreements and spot market sales.

Revenue Mix

The company's primary revenue streams are derived from:

Amines: This segment includes various methylamines and ethylamines, which are basic building blocks for many other chemicals.

Specialty Chemicals & Derivatives: This segment comprises more complex amines and their derivatives tailored for specific applications, as well as pharmaceutical intermediates.

While specific percentage contributions can fluctuate and are not always explicitly broken down by the company for individual products, amines and their derivatives constitute the vast majority of the company's revenue. The company also has a small hospitality segment which is not material to its core chemical business.

Industry

Balaji Amines operates within the Indian specialty chemicals industry, which is characterized by growth driven by increasing domestic demand and global supply chain shifts. The amines market is a niche but critical component of this industry. Balaji Amines holds a strong position as one of the largest manufacturers of aliphatic amines in India. It competes with other domestic players and faces competition from imports, but its scale and product range give it a prominent standing. The industry generally requires significant capital expenditure and adherence to environmental regulations.

MOAT

Backward Integration: Balaji Amines has undertaken significant backward integration for key raw materials like Methylamines and DMF, which helps in cost control, ensures raw material security, and reduces exposure to price volatility of these inputs.

Diversified Product Portfolio: The company produces a wide range of amines and specialty chemicals, catering to multiple industries, which diversifies revenue streams and reduces dependence on any single product or sector.

Established Relationships & Scale: As a long-standing and large producer, it has established strong relationships with customers across various industries and benefits from economies of scale in manufacturing.

Process Expertise: Developing and refining the chemical processes for amine production requires significant technical expertise and operational experience, creating a barrier to entry for new players.

Growth Drivers

Demand from End-User Industries: Continued growth in the pharmaceutical, agrochemical, and rubber industries in India and globally will drive demand for amines and specialty chemicals.

Import Substitution: Government initiatives and a push towards domestic manufacturing (e.g., "Make in India") could encourage import substitution, benefiting local manufacturers like Balaji Amines.

Capacity Expansion: The company's ongoing capital expenditure projects to expand existing capacities and introduce new products are expected to drive volume growth.

New Product Development: Introduction of higher-value specialty chemicals and pharmaceutical intermediates can improve realizations and margins.

China+1 Strategy: Global companies seeking to diversify their supply chains away from China may look to Indian manufacturers, including Balaji Amines.

Risks

Raw Material Price Volatility: The profitability of Balaji Amines is sensitive to fluctuations in the prices of key raw materials like methanol, ammonia, and acetic acid, which are derivatives of crude oil and natural gas.

Environmental & Regulatory Risks: The chemical industry is subject to stringent environmental regulations. Any changes in these regulations or non-compliance could lead to operational disruptions, penalties, or increased costs.

Cyclicality of End-User Industries: Downturns in key end-user sectors like pharmaceuticals or agrochemicals could impact demand for the company's products.

Competition: Intense competition from domestic and international players, including potential new entrants, could put pressure on pricing and margins.

Capex Execution Risk: Delays or cost overruns in ongoing and planned capacity expansion projects could impact future growth projections and financial performance.

Management & Ownership

Balaji Amines is primarily a promoter-driven company, led by the Reddy family. The promoters hold a significant stake in the company, which is common in Indian businesses, indicating strong alignment with shareholder interests. The management team has extensive experience in the chemical industry, particularly in the production of amines and specialty chemicals. The ownership structure generally features a high promoter holding, with the remaining shares held by institutional investors, retail investors, and other entities.

Outlook

Balaji Amines is positioned in a growing segment of the Indian chemical industry, driven by strong demand from domestic and international end-user markets. Its backward integration and diversified product portfolio provide a degree of resilience against market fluctuations and competitive pressures. Planned capacity expansions and focus on specialty chemicals offer a clear path for future growth. However, the company faces inherent risks associated with raw material price volatility, intense competition, and the cyclical nature of its customer industries. Successful execution of expansion plans, effective cost management, and navigating regulatory landscapes will be key to sustaining its growth trajectory and profitability in the coming years.

Balaji Amines Share Price

Live · BSE / NSE · Inception: 1988
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Consolidated · annual

Balaji Amines Quarterly Results

#(Fig in Cr.) Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 414 385 347 313 353 358 341 331 395 456
Other Income 9 8 9 8 8 9 7 5 8 6
Total Income 423 393 356 321 361 367 348 336 403 461
Total Expenditure 316 319 286 267 293 304 281 275 301 340
Operating Profit 106 74 70 54 68 64 67 62 102 121
Interest 1 1 1 1 1 1 1 2 2 1
Depreciation 12 12 12 12 13 14 14 14 14 14
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 93 62 57 41 54 49 52 46 86 106
Provision for Tax 20 16 15 10 13 12 15 15 21 28
Profit After Tax 72 46 41 31 40 37 37 31 65 78
Adjustments -4 -2 -0 2 -0 1 -3 1 -2 -3
Profit After Adjustments 68 43 41 33 40 38 35 31 63 75
Adjusted Earnings Per Share 21 13.4 12.6 10.2 12.4 11.7 10.7 9.7 19.5 23.1

Balaji Amines Profit & Loss

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Net Sales 643 670 861 943 936 1311 2323 2355 1642 1397 1425 1523
Other Income 6 9 12 6 8 11 15 15 30 33 29 26
Total Income 649 679 873 949 944 1323 2338 2371 1671 1430 1454 1548
Total Expenditure 520 521 679 751 758 944 1700 1746 1318 1165 1160 1197
Operating Profit 129 158 194 198 186 379 637 624 353 265 294 352
Interest 22 13 9 13 23 18 17 12 6 4 5 6
Depreciation 19 20 19 20 32 34 42 46 45 48 56 56
Exceptional Income / Expenses 0 1 1 0 0 0 0 0 0 0 0 0
Profit Before Tax 88 126 166 165 131 327 578 567 302 213 232 290
Provision for Tax 30 43 53 48 34 83 160 161 69 55 63 79
Profit After Tax 58 82 113 117 97 243 418 406 232 159 169 211
Adjustments 0 0 0 0 7 -5 -49 -80 -27 -1 -2 -7
Profit After Adjustments 58 82 113 118 105 238 368 326 205 158 167 204
Adjusted Earnings Per Share 17.8 25.4 34.9 36.3 32.3 73.5 113.7 100.5 63.2 48.6 51.6 63

Balaji Amines Balance Sheet

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Shareholder's Funds 278 362 467 574 658 894 1250 1554 1722 1845 1976
Minority's Interest 2 0 18 18 10 16 65 144 171 173 175
Borrowings 46 17 42 83 120 89 58 30 11 2 65
Other Non-Current Liabilities 63 57 64 62 60 69 72 85 94 102 124
Total Current Liabilities 216 199 257 308 264 243 301 149 149 130 402
Total Liabilities 605 635 848 1046 1113 1310 1745 1963 2146 2252 2743
Fixed Assets 341 325 316 320 573 543 676 775 891 998 1038
Other Non-Current Assets 19 30 177 276 79 190 162 155 258 313 764
Total Current Assets 245 280 355 449 461 577 907 1032 997 941 941
Total Assets 605 635 848 1046 1113 1310 1745 1963 2146 2252 2743

Balaji Amines Cash Flow

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Opening Cash & Cash Equivalents 7 9 3 24 20 9 17 33 96 81 149
Cash Flow from Operating Activities 85 60 140 94 144 110 220 354 334 255 184
Cash Flow from Investing Activities -29 -10 -135 -119 -130 -62 -147 -210 -274 -139 -344
Cash Flow from Financing Activities -54 -55 16 21 -26 -37 -57 -81 -75 -49 85
Net Cash Inflow / Outflow 2 -5 21 -4 -12 11 16 63 -15 68 -75
Closing Cash & Cash Equivalent 9 3 24 20 9 20 33 96 81 149 74

Balaji Amines Ratios

# Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Earnings Per Share (Rs) 17.78 25.42 34.93 36.27 32.34 73.51 113.71 100.47 63.22 48.62 51.6
CEPS(Rs) 23.76 31.5 40.88 42.17 39.84 85.77 141.94 139.27 85.7 63.9 69.61
DPS(Rs) 2 2.2 2.6 2.8 3.2 4 6 10 11 11 11
Book NAV/Share(Rs) 85.87 111.87 143.99 177.13 202.99 275.94 385.74 479.69 531.42 569.44 610
Core EBITDA Margin(%) 17.66 20.41 20.81 20.31 18.97 28.06 26.77 25.82 19.71 16.57 18.57
EBIT Margin(%) 15.77 18.98 20 18.88 16.47 26.3 25.59 24.53 18.75 15.49 16.64
Pre Tax Margin(%) 12.6 17.2 18.96 17.5 14.01 24.9 24.86 24.02 18.36 15.22 16.27
PAT Margin (%) 8.25 11.27 12.94 12.42 10.42 18.57 17.96 17.19 14.14 11.32 11.84
Cash Profit Margin (%) 11.03 13.97 15.15 14.49 13.8 21.19 19.77 19.13 16.91 14.78 15.78
ROA(%) 9.39 13.29 15.27 12.37 9.03 20.1 27.35 21.88 11.31 7.21 6.77
ROE(%) 22.77 25.71 27.31 22.51 15.83 31.38 38.98 28.94 14.18 8.89 8.85
ROCE(%) 23.56 30.19 32.21 25.09 17.94 35.58 50.21 39.08 18.37 12.06 12
Receivable days 63.7 62.11 61.97 65.78 73.07 71.4 70.12 74.72 77.47 77.48 79.32
Inventory Days 49.77 44.22 39.25 48.82 53.04 30.44 26.07 40.62 65.52 73.05 66.52
Payable days 49.2 53.28 48.49 55.56 51.29 39.43 38.47 35.6 28.27 34.34 35.34
PER(x) 10.04 14.94 16.11 13.48 7.76 23.98 25.52 19.34 32.33 24.83 18.93
Price/Book(x) 2.08 3.39 3.91 2.76 1.24 6.39 7.52 4.05 3.85 2.12 1.6
Dividend Yield(%) 1.12 0.58 0.46 0.57 1.28 0.23 0.21 0.51 0.54 0.91 1.13
EV/Net Sales(x) 1.15 1.99 2.27 1.9 1.14 4.44 4.07 2.6 3.84 2.55 2.12
EV/Core EBITDA(x) 5.73 8.45 10.08 9.07 5.73 15.34 14.83 9.8 17.83 13.45 10.29
Net Sales Growth(%) 3.94 4.25 28.45 9.5 -0.77 40.15 77.12 1.4 -30.31 -14.89 2
EBIT Growth(%) 28.12 25.9 26.15 1.83 -13.45 123.75 72.63 -2.79 -46.79 -29.57 9.65
PAT Growth(%) 73.55 42.94 37.44 3.45 -16.76 149.82 71.63 -2.92 -42.74 -31.73 6.66
EPS Growth(%) 68.11 42.94 37.44 3.85 -10.84 127.29 54.67 -11.64 -37.07 -23.11 6.14
Debt/Equity(x) 0.62 0.29 0.33 0.4 0.39 0.14 0.08 0.04 0.01 0.01 0.07
Current Ratio(x) 1.14 1.4 1.38 1.46 1.74 2.38 3.02 6.91 6.7 7.26 2.34
Quick Ratio(x) 0.78 0.91 1.03 0.93 1.33 1.92 2.28 4.89 4.78 5.14 1.73
Interest Cover(x) 4.97 10.72 19.34 13.67 6.69 18.85 34.82 48.35 47.81 58.66 44.29
Total Debt/Mcap(x) 0.3 0.09 0.08 0.14 0.32 0.02 0.01 0.01 0 0 0.04

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +2% -15% +2% +8%
Operating Profit CAGR +11% -22% -5% +9%
PAT CAGR +6% -25% -7% +11%
Share Price CAGR +46% -2% -15% +21%
ROE Average +9% +11% +20% +22%
ROCE Average +12% +14% +26% +27%

Balaji Amines Shareholding Pattern

Latest · Jun 2026
100% held
Promoters 54.56 %
FII 3.17 %
DII (MF + Insurance) 1.58 %
Public (retail) 40.69 %
# Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Promoter 53.753.753.753.754.6254.5954.5954.5954.5954.56
FII 4.925.055.275.165.0854.523.32.983.17
DII 1.481.591.791.661.481.471.521.531.461.58
Public 39.939.6739.2439.4838.8238.9539.3740.5840.9740.69
Others 0000000000
Total 100100100100100100100100100100

Balaji Amines Peer Comparison

Chemicals Edit Columns

Balaji Amines Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Balaji Amines Pros & Cons

Pros

  • Company is almost debt free.

Cons

  • Company has a low return on equity of 11% over the last 3 years.
  • Debtor days have increased from 34.34 to 35.34days.
  • Stock is trading at 3.2 times its book value.
  • The company has delivered a poor profit growth of -7% over past five years.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp